Short Interest in Grail, Inc. (NASDAQ:GRAL) Rises By 11.9%

Grail, Inc. (NASDAQ:GRAL - Get Free Report) saw a large increase in short interest in December. As of December 15th, there was short interest totalling 4,900,000 shares, an increase of 11.9% from the November 30th total of 4,380,000 shares. Based on an average trading volume of 800,300 shares, the days-to-cover ratio is currently 6.1 days. Currently, 17.0% of the company's stock are short sold.

Insider Buying and Selling at Grail

In other Grail news, CFO Aaron Freidin sold 30,452 shares of the business's stock in a transaction dated Monday, November 18th. The stock was sold at an average price of $14.02, for a total value of $426,937.04. Following the transaction, the chief financial officer now owns 268,277 shares in the company, valued at $3,761,243.54. The trade was a 10.19 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CEO Robert P. Ragusa sold 123,454 shares of the company's stock in a transaction dated Tuesday, October 15th. The stock was sold at an average price of $14.02, for a total value of $1,730,825.08. Following the completion of the transaction, the chief executive officer now directly owns 612,661 shares in the company, valued at approximately $8,589,507.22. The trade was a 16.77 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have acquired a total of 58,829 shares of company stock valued at $757,298 in the last 90 days.

Analyst Upgrades and Downgrades

GRAL has been the subject of a number of analyst reports. Wolfe Research initiated coverage on shares of Grail in a research note on Friday, November 15th. They issued a "peer perform" rating for the company. Guggenheim began coverage on shares of Grail in a report on Thursday, October 17th. They issued a "neutral" rating for the company. Finally, Morgan Stanley assumed coverage on Grail in a report on Wednesday, November 27th. They set an "equal weight" rating and a $16.00 target price on the stock.

Grail Stock Down 4.9 %

Shares of NASDAQ:GRAL traded down $0.96 during trading on Monday, reaching $18.64. The stock had a trading volume of 533,018 shares, compared to its average volume of 1,080,024. The firm's fifty day moving average is $17.10. Grail has a 52 week low of $12.33 and a 52 week high of $24.92.

About Grail

GRAIL, Inc, a biotechnology company, focuses on developing technologies for early cancer detection. The company develops Galleri, a screening test for asymptomatic individuals over 50 years of age; and DAC, a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients for whom there is a clinical suspicion of cancer.